American International Group’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-28,149
Closed -$814K 2068
2024
Q1
$814K Sell
28,149
-241
-0.8% -$6.97K ﹤0.01% 1408
2023
Q4
$651K Sell
28,390
-115
-0.4% -$2.64K ﹤0.01% 1517
2023
Q3
$475K Buy
28,505
+2,411
+9% +$40.2K ﹤0.01% 1639
2023
Q2
$721K Buy
26,094
+3,638
+16% +$100K ﹤0.01% 1431
2023
Q1
$516K Buy
22,456
+447
+2% +$10.3K ﹤0.01% 1587
2022
Q4
$240K Buy
22,009
+164
+0.8% +$1.79K ﹤0.01% 2038
2022
Q3
$184K Buy
21,845
+308
+1% +$2.59K ﹤0.01% 2201
2022
Q2
$170K Sell
21,537
-673
-3% -$5.31K ﹤0.01% 2297
2022
Q1
$526K Sell
22,210
-1,562
-7% -$37K ﹤0.01% 1693
2021
Q4
$813K Sell
23,772
-711
-3% -$24.3K ﹤0.01% 1538
2021
Q3
$434K Buy
24,483
+1,318
+6% +$23.4K ﹤0.01% 1956
2021
Q2
$1.04K Buy
23,165
+2,638
+13% +$118 ﹤0.01% 1493
2021
Q1
$532 Buy
20,527
+2,224
+12% +$58 ﹤0.01% 1802
2020
Q4
$369 Buy
18,303
+188
+1% +$4 ﹤0.01% 1924
2020
Q3
$354K Buy
18,115
+4,306
+31% +$84.1K ﹤0.01% 1784
2020
Q2
$244K Buy
13,809
+3,370
+32% +$59.5K ﹤0.01% 2011
2020
Q1
$74K Sell
10,439
-602
-5% -$4.27K ﹤0.01% 2490
2019
Q4
$78K Buy
11,041
+286
+3% +$2.02K ﹤0.01% 2741
2019
Q3
$129K Buy
10,755
+1,113
+12% +$13.4K ﹤0.01% 2449
2019
Q2
$117K Buy
+9,642
New +$117K ﹤0.01% 2587
2018
Q2
Sell
-7,285
Closed -$63K 3108
2018
Q1
$63K Sell
7,285
-392
-5% -$3.39K ﹤0.01% 2842
2017
Q4
$160K Buy
7,677
+1,389
+22% +$28.9K ﹤0.01% 2455
2017
Q3
$111K Buy
6,288
+470
+8% +$8.3K ﹤0.01% 2612
2017
Q2
$66K Buy
5,818
+1,254
+27% +$14.2K ﹤0.01% 2921
2017
Q1
$58K Buy
+4,564
New +$58K ﹤0.01% 2799